September 13, 2017 / 4:21 PM / 13 days ago

BRIEF-Medipost receives patent

Sept 14 (Reuters) - Medipost Co Ltd :

* Says it received patent on Sep. 13, for pharmaceutical composition for the prevention or treatment of a lung disease comprising mesenchymal stem cells having improved proliferation and differentiation capacity

* Patent number is 10-2016-0025484

Source text in Korean: goo.gl/1Cua5m

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below